lunes, 25 de septiembre de 2023

Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study

https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-023-01636-8

No hay comentarios:

Publicar un comentario